Global Animal Antibiotics Antimicrobials Market
Marktgröße in Milliarden USD
CAGR :
% 
 Prognosezeitraum |
2024 –2031 |
 Marktgröße (Basisjahr) | USD 4.88 Billion |
 Marktgröße (Prognosejahr) | USD 6.73 Billion |
 CAGR |
% |
| Wichtige Marktteilnehmer |
|
Global Animal Antibiotics Antimicrobials Market Segmentation, By Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Fluoroquinolone, Lincosamides, Cephalosporins), Mode of Delivery (Premixes, Oral Powder, Injection, Others), Animal Type (Food-producing Animals, Companion Animals) – Industry Trends and Forecast to 2031.
Animal Antibiotics Antimicrobials Market Analysis
Over the last few years, there has been increased consumption of animal-derived food items, rising demand for dairy products and an increase in cattle population enabled by organized farming. These determinants further propel the demand for the animal antibiotics antimicrobials. The growth in the overall companion animal population especially China, India and Brazil has leads to the substantial expansion of the market over the forecasted period.
Animal Antibiotics Antimicrobials Market Size
Global animal antibiotics antimicrobials market size was valued at USD 4.88 billion in 2023 and is projected to reach USD 6.73 billion by 2031, with a CAGR of 4.10% during the forecast period of 2024 to 2031.
Report Scope and Market Segmentation
|
Attributes |
Animal Antibiotics Antimicrobials Key Market Insights |
|
Segmentation |
|
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. |
|
Key Market Players |
Abbott (U.S.), Allergan (Ireland), Merck & Co., Inc. (U.S.), Pfizer Inc. (U.S.), GlaxoSmithKline plc (U.K.), Abbott (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd.(Jerusalem), Sanofi (France), Novartis AG (Switzerland), Bayer AG (Germany), Sun Pharmaceutical Industries Ltd. (Mumbai), Aurobindo Pharma (Hyderabad), Lupin (Mumbai), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), Zydus Cadila (Ahmedabad), Dr. Reddy's Laboratories Ltd. (Hyderabad), Apotex Inc. (Canada) |
Animal Antibiotics Antimicrobials Market Definition
Antimicrobials are substances that kill or inhibit the majority of germs. The antimicrobials can be natural, semi-synthetic, or synthetic. Antibiotics are all antimicrobials, but antimicrobials aren't all antibiotics. Antibiotics are basically used to treat clinical illness, prevent and manage common disease occurrences, and improve animal development and growth. They are used in food animals in three ways: therapeutic, prophylactic, and sub-therapeutic. Antimicrobials offer significant advantages in terms of animal and human food safety. Antibiotics and antimicrobials used in animals can contribute to the spread of antimicrobial resistance in bacteria that can be transmitted to people, reducing the efficacy of antimicrobial medications for treating human illnesses.
Animal Antibiotics Antimicrobials Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
Drivers
- Growing Concerns For the Animal Health
There has been rising concerns regarding the health of animals. The rising animal healthcare spending and the growing demand for pet insurance will lead to high demand for animal antibiotics antimicrobials, which is the most significant factor driving the growth for this market. Increasing initiatives concerning animal health and welfare along with increasing incidence of zoonotic diseases are also expected to accelerate the overall growth of the market.
Furthermore, the rapid growth in the consumption of products such as meat and seafood on regular basis also triggers the market growth. The rising demand for animal-derived food products and the implementation of regulations to prevent the spread of animal diseases are also projected to cushion the growth of the market. Moreover, the unused prospects of the advancing markets and the development in the companion animal populace are estimated to generate lucrative opportunities for the market. The surging demand for dairy products, and subsequent rise in livestock population facilitated by organized farming which will further expand the animal antibiotics antimicrobials market's growth rate in the future.
Restraints/Challenges
- Strict Acceptance Process
There has been the increasing resistance to the antimicrobials. The strict acceptance procedure for the antimicrobials and antibiotics is expected to create hindrances for the market growth.
Also, the factors such as the shortage of the new antibiotics and the repetitive preventive utilization of the antibiotics being substituted by the good husbandry and the sanitization practices are projected to challenge the animal antibiotics antimicrobials market in the forecast period of 2024-2031.
This animal antibiotics antimicrobials market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the animal antibiotics antimicrobials market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Post Covid-19 Impact on Animal Antibiotics Antimicrobials Market
The animal antibiotics antimicrobials market was moderately impacted by the outbreak of COVID-19. Imposition of the stringent lockdown and social distancing restrictions by the government to curb the COVID-19 pandemic outbreak, led to halt of various manufacturing operations, supply chain disruptions, stifling business growth, technology event cancellations, suspensions of new developments and has affected the overall production and sales, limiting the industry's expansion. The adoption of alternative sources, such as plant-based ingredients also hindered the growth of the market.
Moreover, the surge in Antimicrobial Resistance (AMR) in people and animals is projected in the post-COVID scenario, owing to increased demand on antibiotic-dependent healthcare systems to treat secondary bacterial infections. Antibiotic stewardship initiatives in hospitals and communities were interrupted, and antibiotics were prescribed for COVID patients misdiagnosed with bacterial bronchitis, over-prescription in telehealth consultations, and easy access to drugs from internet pharmacies were all linked to AMR. This is resulted in negative impact on consumers toward animal-sourced products.
Animal Antibiotics Antimicrobials Market Scope
The animal antibiotics antimicrobials market is segmented on the basis of product, mode of delivery and animal type. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Tetracycline
- Penicillin
- Sulfonamide
- Macrolide
- Cephalosporin
- Fluoroquinolone
- Lincosamides
- Cephalosporins
On the basis of product, the animal antibiotics antimicrobials market is segmented into tetracycline, penicillin, sulfonamide, macrolide, cephalosporin, fluoroquinolone, lincosamides and cephalosporins. The tetracyclines segment accounts for the largest share owing to its factors such as well-absorbed, low toxicity, high potency against pathogenic microorganisms and are relatively inexpensive compared to other animal antimicrobial and antibiotic products.
Mode of Delivery
- Premixes
- Oral Powder
- Injection
- Others
On the basis of mode of delivery, the animal antibiotics antimicrobials market is segmented into premixes, oral powder, injection and others.
Animal Type
- Food-producing Animals
- Companion Animals
On the basis of animal type, the animal antibiotics antimicrobials market is bifurcated into food-producing animals and companion animals.
Animal Antibiotics Antimicrobials Market Regional Analysis
The animal antibiotics antimicrobials market is analyzed and market size insights and trends are provided by country, product, mode of delivery and animal type as referenced above.
The countries covered in the animal antibiotics antimicrobials market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the animal antibiotics antimicrobials market because of the high companion animal ownership, increasing incidences of animal diseases coupled with the huge capital investments for the development of drugs for animal diseases within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2024 to 2031 due to the increasing government involvement in countering animal diseases outbreaks, increasing livestock population along with the growing demand for animal antimicrobials within the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The animal antibiotics antimicrobials market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for animal antibiotics antimicrobials market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the animal antibiotics antimicrobials market. The data is available for historic period 2010-2020.
Animal Antibiotics Antimicrobials Market Share
The animal antibiotics antimicrobials market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to animal antibiotics antimicrobials market.
Animal Antibiotics Antimicrobials Market Leaders Operating in the Market Are:
- Boehringer Ingelheim International GmbH. (Germany)
- Zoetis (US)
- Elanco (US)
- Merck & Co. Inc. (US)
- Phibro Animal Health Corporation (US)
- Virbac (France)
- Vetoquinol (France)
- HIPRA (Spain)
- Ceva (France)
- Dechra (UK)
- Kyoritsuseiyaku Corporation (Japan)
- CHINA ANIMAL HUSBANDRY GROUP (China)
- Endovac Animal Health (US)
- Zydus Group (India)
- Indian Immunologicals Pvt. Ltd. (India)
- UCBVET Saúde e Bem Estar Animal (US)
- American Reagent Inc. (US)
- Neogen Corporation (US)
- Huvepharma (US)
- Ayurvet (India)
- Ashish Life Science (India)
- Inovet Group (Belgium)
- Lutim Pharma Private Limited (India)
- ECO Animal Health Ltd (US)
Latest Developments in Animal Antibiotics Antimicrobials Market
- In July 2020, Trianni Inc. (US) and Zoetis (US) have agreed to collaborate on the development of transgenic monoclonal antibody platforms for the identification of novel veterinary medicines. The FDA authorised the purchase of Marboquin for Zoetis (US).
SKU-
Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud
- Interaktives Datenanalyse-Dashboard
- Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
- Zugriff für Research-Analysten für Anpassungen und Abfragen
- Konkurrenzanalyse mit interaktivem Dashboard
- Aktuelle Nachrichten, Updates und Trendanalyse
- Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Forschungsmethodik
Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.
Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.
Anpassung möglich
Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.
